BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3747696)

  • 1. Amelioration of cisplatin-induced ototoxicity by fosfomycin.
    Schweitzer VG; Dolan DF; Abrams GE; Davidson T; Snyder R
    Laryngoscope; 1986 Sep; 96(9 Pt 1):948-58. PubMed ID: 3747696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents.
    Schweitzer VG
    Laryngoscope; 1993 Apr; 103(4 Pt 2):1-52. PubMed ID: 8464301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ototoxicity of cisplatin vs. platinum analogs CBDCA (JM-8) and CHIP (JM-9).
    Schweitzer VG; Rarey KE; Dolan DF; Abrams G; Litterst CJ; Sheridan C
    Otolaryngol Head Neck Surg; 1986 Apr; 94(4):458-70. PubMed ID: 3086808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin ototoxicity in guinea pigs with special reference to toxic effects in the stria vascularis.
    Kohn S; Fradis M; Pratt H; Zidan J; Podoshin L; Robinson E; Nir I
    Laryngoscope; 1988 Aug; 98(8 Pt 1):865-71. PubMed ID: 3398664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental studies of the nephroprotective effect of fosfomycin].
    Kreft B; Marre R; Schulz E; Sack K
    Wien Med Wochenschr; 1987 Feb; 137(4):83-8. PubMed ID: 2954305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fosfomycin does not inhibit the tumoricidal efficacy of cisplatinum.
    Jordan JA; Schwade ND; Truelson JM
    Laryngoscope; 1999 Aug; 109(8):1259-62. PubMed ID: 10443830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity.
    Cooper LB; Chan DK; Roediger FC; Shaffer BR; Fraser JF; Musatov S; Selesnick SH; Kaplitt MG
    Otol Neurotol; 2006 Jun; 27(4):484-90. PubMed ID: 16791039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ototoxicity after combined platinum and fractionated radiation in a novel guinea pig model.
    Miller MW; Riedel G; Hoistad D; Sutherland C; Juhn SK; Adams GL; Griffin R; Ondrey FG
    Am J Otolaryngol; 2009; 30(1):1-7. PubMed ID: 19027506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo interaction of cis-platinum and fosfomycin on squamous cell carcinoma.
    Tandy JR; Tandy RD; Farris P; Truelson JM
    Laryngoscope; 2000 Jul; 110(7):1222-4. PubMed ID: 10892700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratympanic dexamethasone to prevent cisplatin ototoxicity: a guinea pig model.
    Murphy D; Daniel SJ
    Otolaryngol Head Neck Surg; 2011 Sep; 145(3):452-7. PubMed ID: 21521888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ototoxicity, nephrotoxicity and pharmacokinetics of cisplatin and its monohydrated complex in the guinea pig.
    Ekborn A; Lindberg A; Laurell G; Wallin I; Eksborg S; Ehrsson H
    Cancer Chemother Pharmacol; 2003 Jan; 51(1):36-42. PubMed ID: 12497204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of increased activities of Na+, K+-ATPase and Ca2+-ATPase with the reversal of cisplatin ototoxicity induced by D-methionine in guinea pigs.
    Cheng PW; Liu SH; Hsu CJ; Lin-Shiau SY
    Hear Res; 2005 Jul; 205(1-2):102-9. PubMed ID: 15953519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reduction of cisplatin toxicity by fosfomycin in animal models].
    Ohtani I; Ohtsuki K; Aikawa T; Sato Y; Anzai T; Ouchi J; Saito T
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2400-7. PubMed ID: 6541892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhalation of hydrogen gas attenuates cisplatin-induced ototoxicity via reducing oxidative stress.
    Qu J; Li X; Wang J; Mi W; Xie K; Qiu J
    Int J Pediatr Otorhinolaryngol; 2012 Jan; 76(1):111-5. PubMed ID: 22055279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astragalosides reduce cisplatin ototoxicity in guinea pigs.
    Xiong M; He Q; Wang J; Lai H
    ORL J Otorhinolaryngol Relat Spec; 2011; 73(3):131-6. PubMed ID: 21494054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats.
    Huang X; Whitworth CA; Rybak LP
    Otol Neurotol; 2007 Sep; 28(6):828-33. PubMed ID: 17450108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ototoxic and nephrotoxic effects of combined treatment with cis-diamminedichloroplatinum and kanamycin in the guinea pig.
    Schweitzer VG; Hawkins JE; Lilly DJ; Litterst CJ; Abrams G; Davis JA; Christy M
    Otolaryngol Head Neck Surg; 1984 Feb; 92(1):38-49. PubMed ID: 6422414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity.
    Muldoon LL; Pagel MA; Kroll RA; Brummett RE; Doolittle ND; Zuhowski EG; Egorin MJ; Neuwelt EA
    Clin Cancer Res; 2000 Jan; 6(1):309-15. PubMed ID: 10656463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery of hearing following cisplatin ototoxicity in the guinea pig.
    O'Leary SJ; Klis SF
    Anticancer Res; 2002; 22(3):1525-8. PubMed ID: 12168832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental study of the ototoxicity of cisplatinum].
    Basterra J; Marco Algarra J; González Devesa M; Marco J; Pellin A
    An Otorrinolaringol Ibero Am; 1985; 12(2):157-66. PubMed ID: 4039900
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.